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Madlp, a Phosphoprotein Component of the 
Spindle Assembly Checkpoint in Budding Yeast 
Kevin G. Hardwick and Andrew W. Murray 
Department ofPhysiology, University of California, San Francisco, California 94143-0444 
Abstract. The spindle assembly checkpoint prevents 
cells from initiating anaphase until the spindle has been 
fully assembled. We previously isolated mitotic arrest 
deficient (mad) mutants that inactivate this checkpoint 
and thus increase the sensitivity of ceils to benomyl, a
drug that interferes with mitotic spindle assembly by 
depolymerizing microtubules. We have cloned the 
MAD1 gene and show that when it is disrupted yeast 
cells have the same phenotype as the previously iso- 
lated mad! mutants: they fail to delay the metaphase to 
anaphase transition in response to microtubule depoly- 
merization. 
MAD1 is predicted to encode a 90-kD coiled-coil 
protein. Anti-Madlp antibodies give a novel punctate 
nuclear staining pattern and cell fractionation reveals 
that the bulk of Madlp is soluble. Madlp becomes hy- 
perphosphorylated when wild-type ceils are arrested in 
mitosis by benomyl treatment, or by placing a cold sen- 
sitive tubulin mutant at the restrictive temperature. 
This modification does not occur in Gl-arrested cells 
treated with benomyl or in cells arrested in mitosis by 
defects in the mitotic cyclin proteolysis machinery, sug- 
gesting that Madlp hyperphosphorylation is a step in 
the activation of the spindle assembly checkpoint. 
Analysis of Madlp phosphorylation in other spindle as- 
sembly checkpoint mutants reveals that this response to 
microtubule-disrupting agents is defective in some 
(mad2, bubl, and bub3) but not all (mad3, bub2) mu- 
tant strains. We discuss the possible functions of Madlp 
at this cell cycle checkpoint. 
CURATE chromosome r plication and segregation re- 
quire mechanisms that can detect errors in these 
processes and initiate two responses: repair sys- 
tems that correct he errors, and delay mechanisms that 
prevent he cell cycle from proceeding while the repairs 
are in progress. The combined etection and delay systems 
are known as cell cycle checkpoints or feedback controls 
(reviewed in Hartwell and Weinert, 1989; Murray, 1994, 
1995). 
Genetic analyses in both budding and fission yeast have 
identified a number of genes that play a role in ensuring 
that cells complete DNA replication and repair DNA 
damage before they enter mitosis (Weinert and Hartwell, 
1988; Enoch and Nurse, 1990; AI-Khodairy and Carr, 1992; 
Rowley et al., 1992; Enoch et al., 1992; Weinert et al., 1994; 
A1-Khodairy et al., 1994, 1995; Ford et al., 1994). For ex- 
ample, the RAD9 gene is required to arrest he cell cycle 
in response to DNA damage, but is not required for the 
process of DNA repair (Weinert and Hartwell, 1988). This 
cell cycle control is not essential for growth in the absence 
of DNA damage, but irradiated rad9 cells are unable to 
Address all correspondence to A. W. Murray, Department of Physiology, 
Box 0444, University of California, 513 Parnassus Avenue, San Francisco 
CA 94143-0444. Ph.: (415) 476-0364. Fax: (415) 476-4929. 
delay their passage through mitosis in response to the dam- 
aged DNA and produce lethally damaged progeny. 
The mitotic arrest caused by microtubule polymeriza- 
tion inhibitors uggests the existence of a spindle assembly 
checkpoint that monitors the status of the spindle and reg- 
ulates the metaphase to anaphase transition. The ability of 
single improperly oriented chromosomes (Callan and Ja- 
cobs, 1957; Li and Nicklas, 1995; Rieder et al., 1994), par- 
tially defective centromeres (Spencer and Hieter, 1992), 
and excess centromeres (Futcher and Carbon, 1986; Wells, 
W., and A. W. Murray, unpublished results) to delay ana- 
phase suggests that this checkpoint can detect subtle as 
welt as gross defects in the structure of the spindle. Mu- 
tants in the spindle assembly checkpoint have been identi- 
fied in budding yeast. The bub (budding uninhibited )y  
benzimidazole; Hoyt et al., 1991) and mad (mitotic arr¢st 
deficient; Li and Murray, 1991) mutants were isolated 
from collections of mutants that failed to form colonies in 
the presence of low doses of benomyl, amicrotubule poly- 
merization inhibitor. The mad mutants were distinguished 
from mutants that affected microtubule assembly by their 
inability to delay cell division in response to microtubule 
depolymerization. The divisions that take place in the ab- 
sence of a fully functional spindle lead to a high frequency 
of chromosome loss and cell death (Li and Murray, 1991). 
The spindle assembly checkpoint defined by the mad and 
© The Rockefeller University Press, 0021-9525/95/11/709/12 $2.00 
The Journal of Cell Biology, Volume 131, Number 3, November 1995 709-720 709 
Table I. 
Yeast strains 
KH 34 a 
KH 35 ct 
KH 36 a/a 
KH 120 a 
BEN 24 a 
BEN 27 a 
BEN 79 a 
KH 123 a 
KH 131 a 
KH 132 a 
KH 125 a 
KH 40 a 
KH 127 a 
KH 128 a 
MAY 2072 a 
KH 161 a 
KH 162 a 
KH 152 a 
KH 146 a 
ura3-1, leu2,3-112, his3-11, trp l- l , ade2-1, can l- l O0 
ura3-1, 1eu2,3-112, his3-11, trp t-1, ade2-1, can l- l O0 
ura3-1/ura3-1, leu2,3-112/leu2,3-112, his3-11/his3-11, trp l-1/trp l- l , ade2-1/ade2-1, can l- l OO/can l- l O0 
mad1-1, his3, leu2, ura3-52 
mad1-1, his3, leu2, ura3-52, rad9A::LEU2 
mad1-2, his3, leu2, ura3-52, rad9A::LEU2 
mad1-3, his3, leu2, ura3-52, rad9A::LEU2 
madl~l.l::HlS3, ura3-1, Ieu2,3-12, his3-11, trpl-1, ade2-1, canl-lO0 
madl A.2::URA3, ura3-1, 1eu2,3-112, his3-11, trpl-1, ade2-1, canl-lO0 
mad2-1, ura3-1, 1eu2,3-112, his3-11, trpl-1, ade2-1, canl-lO0 
mad3A::LEU2, ura3-1, leu2,3-112, his3-11, trpl-1, ade2-1, canl-lO0 
cinl A::HIS3, ura3-1, leu2,3-112, his3-11, trpl-1, ade2-1, canl-lO0 
bubl A::HIS3, ura3-1, leu2,3-112, his3-11, trpl-1, ade2-1, canl-lO0 
bub2A::URA3, ura3-1, 1eu2,3-112, his3-11, trpl-l, ade2-1, canl-lO0 
bub3A::LEU2, ura3-52, 1eu2,3-112, his3-A200, lys2-801 
cdc15-2, ura3-1, 1eu2,3-112, his3-11, trpl-1 
cdc23, ura3-1, leu2,3-112, trpl-1, ade2-1 
tub2-403, ura3-52, leu2,3-112, lys2-801 
ura3-52, leu2,3-112, trpl-1 
bub mutants is expected to consist of components hat de- 
tect defects in spindle structure, and a signal transduction 
pathway that relays this information and ultimately inhib- 
its a target in the machinery that initiates ister chromatid 
separation and anaphase. In common with other cell cycle 
transitions a major regulator of the metaphase toanaphase 
transition is thought o be the kinase activity of Cdc28p- 
mitotic cyclin complexes (for reviews see Norbury and 
Nurse, 1992; Morgan, 1995). Experiments in frog egg ex- 
tracts and in yeast have shown that the ubiquitin-mediated 
proteolysis of mitotic cyclins and other proteins is required 
for sister chromatid separation and entry into the next cell 
cycle (Holloway et al., 1993; Surana et al., 1993). 
Little is known about he biochemical mechanism of the 
spindle assembly checkpoint. Previous work has shown 
that BUB1 encodes aprotein kinase (Roberts et al., 1994) 
and that BUB2, BUB3 (Hoyt et al., 1991), and MAD2 
(Chen, R-H., and A. W. Murray, unpublished results) en- 
code proteins with unknown biochemical functions. Here 
we report he cloning of the MAD1 gene and show that it 
encodes a novel nuclear phosphoprotein that is an essen- 
tial component of the spindle assembly checkpoint, but is 
not essential for growth under normal conditions. We find 
that this protein is hyper-phosphorylated in conditions 
that activate the spindle assembly checkpoint. The hyper- 
phosphorylation f Madlp is only seen in a subset of mad 
and bub mutants allowing us to provisionally order the 
function of the known BUB and MAD genes. 
Materials and Methods 
Yeast Strains and Media 
Table 1 lists the strains used in this work. The original madl mutants were 
isolated in the A364A background. All other strains are derivatives of 
W303, except he bub3A strain MAY 2072 (Hoyt et aI., 1991) and the 
tub2-403 (KH 152) and corresponding TUB2 control (KH146) strain 
which are $288C derived. Media were prepared and genetic manipulations 
were performed as described (Sherman et al., 1974). Stock solutions of in- 
hibitors were: benomyl 30 mg/ml in DMSO (added to hot media to main- 
tain solubility), hydroxyurea 200 mg/ml in water, and a-factor 10 mg/ml in 
DMSO. Microcolony assays were carried out as previously described (Li 
and Murray, 1991). 
Cloning of MAD1 
Earlier attempts to clone the MAD1 gene using centromeric and multi- 
copy libraries were unsuccessful, although we isolated a number of multi- 
copy suppressors that conferred benomyl resistance on a variety of mad 
mutants and a mutant (cinlA) with defects in microtubule polymerization 
(Stearns et al., 1990). These suppressors included the transcription factors 
YAP1 (also named PAR1, SNQ3, and PDR4) and CAD1 along with a 
novel member of the hsp70 family, whose sequence will be reported else- 
where. The two transcription factors had been previously isolated in 
multi-copy suppressor screens due to their ability to confer multi-drug re- 
sistance on yeast cells (Moye-Rowley et al, 1989; Hussain and Lenard, 
1991; Schnell et al., 1992; Wu et al., 1993). 
Assuming that the MAD1 gene was not present, or was at best poorly 
represented, in the available libraries, we constructed a new YCP50-based 
genomic library. We prepared genomic DNA as previously described 
(Philippsen et al., 1991) from W303 strain KH 34, carried out a partial 
Sau3A digest, isolated 6-10-kb fragments, and ligated them to BamHI cut 
and phosphatase-treated YCP50 (Rose et al., 1987). This ligation was 
transformed into Escherichia coli strain XL1-Blue MRF (Stratagene, La 
Jolla, CA) and four pools of ~10,000 colonies each were used to isolate 
plasmid DNA. This library DNA was then used to transform the mad1-1 
strain KH 120. After two to three days of growth on uracil-free plates the 
Ura ÷ yeast transformants were scraped off, diluted, and replated onto 
YPD plates containing 10 Ixg/ml benomyl. Plasmid DNA was prepared 
(Ward and Kirschner, 1990) from benomyl-resistant colonies and individ- 
ual plasmid isolates were re-tested for their ability to confer benomyl re- 
sistance to KH 120. One plasmid, pKH130, with a 6.2-kb insert, had this 
property. A 3.2-kb HindlII-SalI fragment from this plasmid was sufficient 
to complement madl strains. This fragment contained unique XhoI and 
XbaI sites. When either the XhoI or the XbaI restriction site was filled in, 
the resulting clone no longer complemented the madl mutant, suggesting 
that these sites lay within, or near, the complementing gene. 
To check that the HindlII-Sall fragment contained the MAD1 gene 
rather than a suppressor we cloned the flanking HindlII fragment into the 
URA3-containing integration vector pRS306 (Sikorski and Hieter, 1989). 
This construct was cut with BgllI then transformed into the mad1, ura3 
strain, KH 120, to create a mad1 strain in which the genomic locus of the 
cloned gene was marked with URA3. This strain was then mated with KH 
35, a MAD1, ura3 strain, the resulting diploids were sporulated and tet- 
fads were dissected. In 10 tetrads the mad phenotype co-segregated with 
the Ura + spores, confirming that the sequences in pKH130 are closely 
linked to MAD1. 
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Sequencing, Mapping, and madl Gene Disruptions 
We sequenced the whole of the 3,188-bp HindIII-Sal! fragment, after sub- 
cloning various fragments into pBluescript and making ExoIII deletion se- 
ries (Henikoff, 1984). We found a single large open reading frame that is 
predicted to encode a protein of 749 amino acids. The sequence of this 
reading frame was completed and confirmed on the second strand using 
specifically designed primers. 
The MAD1 reading frame was used to make a digoxygenin-labeled 
probe with a DNA labeling kit (Boehringer-Mannheim Corp., Indianapo- 
lis, IN) following the manufacturers instructions. This was used to probe a 
set of filters purchased from the American Type Culture Collection 
(Rockville, MD) that have DNA from lambda nd cosmid clones covering 
over 96% of the genome of Saccharomyces cerevisiae cross-linked to 
them. The MAD1 probe specifically recognized a single lambda clone 
(70269) thereby mapping it to the left arm of chromosome VII between 
RAD6 and CYH2. 
Two mad1 gene disruptions were made (see Fig. 1): one, madlA.1, re- 
places the HinclI fragments from nucleotides 994 to 2,186 with a BamHI 
fragment containing the HIS3 gene (pKH149). The other, madlA.2, re- 
places almost he complete MAD1 reading frame from the BgllI site at 
position 76 to the XmnI site at 1911 with the URA3 marker (pKH160). 
These constructs were used to transform haploid and diploid strains (KH 
34, 35, and 36). Benomyl-sensitive haploid transformants were recovered 
and the gene disruptions confirmed using both PCR and Western blotting 
analyses (see Fig. 4). 
Preparation of Antibodies against Madlp, 
Immunoblotting, and Immunofluorescence 
The BgllI fragment encoding residues 27 to 310 of Madlp was cloned into 
the BamHI site of pGEX3X (Smith and Johnson, 1988). This glutathione- 
S-transferase (GST) 1 fusion construct was transformed into E. coli strain 
HB101 and its expression i duced with 0.1 mM IPTG for 3 h at room tem- 
perature. Cells were pelleted and resuspended on ice with PBS (140 mM 
Na2HPO4, 1.8 mM KH2PO4, 138 mM NaCI, 2.7 mM KCI, pH 7.2), repel- 
leted, and frozen in liquid nitrogen. The frozen cells were resuspended in 
five volumes of PBS containing i mM EDTA, i mM EGTA, i mM MgCI2, 
1 mM PMSF, 200 p.g/ml ysozyme, and 5 v.g/ml DNase. To complete their 
lysis the cells were sonicated briefly. KC1 was added to 0.25 M and DTT to 
15 mM and the lysate was spun at 35,000 rpm in a rotor (model 50.2 Ti; 
Beckman Instruments, Palo Alto, CA) for 1 h. The supernatant was then 
loaded onto a 10 ml glutathione agarose column (Sigma Chemical Co., St. 
Louis, MO) which was then washed with PBS containing 0.25 M KCI and 
0.5 mM DTr.  The Madl-GST fusion protein was eluted with 5 mM re- 
duced glutathione in 50 mM Tris, pH 8.1, 0.25 M KC1. The peak fractions 
Were dialyzed extensively into 50 mM Hepes, pH 7.6, 50 mM KCI, 30% 
glycerol. This protein was sent to Berkeley Antibody Company (Berkeley, 
CA) where it was used to immunize a rabbit. The rabbit serum was passed 
over a 50 ml column of GST fusion protein coupled to Affigel I0 (Bio-Rad 
Labs, Hercules, CA) to remove anti-GST antibodies, then affinity purified 
using a 5 ml column of the Madlp-GST fusion protein coupled to Affi- 
gel 10. 
Yeast extracts for immunoblotting were made by bead-beating cells in 
SDS sample buffer (80 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 10 mM 
EDTA, 0.0013% Bromphenol blue, 50 mM NaF, 100 IxM NaVanadate, 1 
mM PMSF and LPC [10 ixg/ml leupeptin, pepstatin, and chymostatin]). 
Standard methods were used for SDS-PAGE and protein transfer to ni- 
trocellulose (Harlow and Lane, 1988). Blots were stained with Ponceau S 
to confirm transfer and equal protein loading, then blocked for 30 min 
with blotto (4% dried milk, PBS, 0.1% Tween 20). The affinity-purified 
anti-Madlp antibody (0.5 mg/ml glycerol stock) was used at a dilution of 
1:5,000 in blotto, and the anti-Clb2p antibody (1 mg/ml glycerol stock; 
kindly provided by Doug Kellogg, University of California, Santa Cruz, 
CA) at 1:1,500, either overnight at 4°C or for 2 h at room temperature. Af- 
ter washing extensively in PBS the blots were then incubated with HRP- 
conjugated anti-rabbit antibodies (Amersham Corp., Buckinghamshire, 
UK) at a 1:5,000 dilution, washed again, and developed using Amersham 
ECL detection reagents following the manufacturer's in tructions. 
The affinity-purified anti-Madlp antiserum still recognizes a number 
of other proteins in addition to Madlp on immunoblots ofwhole yeast cell 
1. Abbreviations used in this paper: GST, glutathione-S-transferase; LPP, 
lambda protein phosphatase. 
extracts including a prominent band at 85 kD (see Fig. 4). However, these 
cross-reacting proteins are not immunoprecipitated by the antibody (see 
Fig. 9), nor are they recognized well in formaldehyde-fixed yeast cells (see 
Fig. 5), suggesting that they are unlikely to be closely related to Madlp. 
Attempts have been made to reduce the background on the immunoblots, 
by using higher salt concentrations and other blocking agents such as 
BSA, but the conditions used here provide the optimal detection of 
Madlp and its hyperphosphorylated forms. 
For solubility studies, spheroplasts were prepared by treating logarith- 
mically growing cells (KH 34) with 100 mM Tris, pH 9.4, 10 mM DT'F for 
10 min at room temperature, and then digesting the cell wails with lyticase 
in YPD containing 0.7 M sorbitol and 10 mM Tris, pH 7.4, for 15 min at 
30°C. Spheroplasts were washed and allowed to recover for 30 min at 
room temperature in YPD containing 0.7 M sorbitol, washed in ice-cold 
lysis buffer (0.2 M sorbitol, 20 mM Hepes, pH 6.8, 50 mM KOAc, 2 mM 
EDTA, 0.5 mM EGTA, LPC, 1 mM PMSF), and then dounced 20 times. 
This homogenate was spun at 7,000 g in a Beckman TL100.3 rotor and the 
pellet resuspended in lysis buffer and dounced and spun once again to re- 
move any remaining whole cells and debris. DTT was added to 1 mM to 
the pooled supernatants, and aliquots were treated with the following: 1% 
Triton X-100, 1 M NaCI or 1% Triton X-100 with 1 M NaC1 and 0.25 rag/ 
ml DNase/RNase. After 60 min the extracts were spun at 50,000 rpm in a 
Beckman TL100.2 rotor for 30 min. The supernatant fractions were pre- 
cipitated with TCA and equivalent fractions of pellet and supernatant 
fractions eparated by SDS-PAGE. 
For gel filtration, yeast extracts were made by bead-beating whole cells 
(KH 34) in 50 mM Hepes, pH 7.6, 25 mM KCI, 50 mM NaF, 1 mM MgC12, 
1 mM EGTA, 0.1% NaDeoxycholate, 10% glycerol, LPC, 1 mM PMSF, 
0.5 mM DTI'. The lysate was spun briefly to remove the glass beads and 
cell debris and then spun for 30 min at 55,000 rpm in a Beckman TL100.2 
rotor. 200 p.1 was loaded on to a Superose 6 HR 10/30 column (Pharmacia 
Biotech Inc., Piscataway, NJ) running at 0.3 ml/min and 0.5 ml fractions 
were collected. For sucrose-gradient centrifugation a bead-beaten extract 
was made in 50 mM Hepes, pH 7.6, 50 mM KC1, 50 mM NaF, 1 mM 
MgCI 2, 1 mM EGTA, 0.1% NaDeoxycholate, LPC, I mM PMSF, 0.5 mM 
DTT, and spun for 30 min at 55,000 rpm in a TL100.2 rotor. A 2 ml su- 
crose gradient (5--40%) was made using a SG5 gradient mixer (Hoefer 
Scientific Instruments, San Francisco, CA), 100 p.l of extract was loaded 
on top, and spun in a TLS55 swinging-bucket rotor at 55,000 rpm for 14 h. 
75 l.d fractions were taken from the top of the gradient. The sucrose gradi- 
ent and the gel filtration column were calibrated with markers from a 
Pharmacia high molecular weight calibration kit. 
For immunofluorescence, spheroplasts were prepared as above then 
fixed with 3.7% formaldehyde for 5 to 30 min, gently sedimented, washed, 
and resuspended in 0.7 M sorbitol, 0.1 M KPO4, pH 7.5, before being at- 
tached to poly-lysine--coated multi-well microscope slides. The slides were 
plunged into methanol (-20°C) for 5 min and acetone (-20°C) for 30 s, 
and then allowed to air dry. After washing with PBS, cells were blocked 
for 30 min with blotto, and then stained overnight at 4°C with primary an- 
tibody diluted (1:5,000 for anti-Madlp, 1:200 for anti-tubulin, 1:1,000 for 
anti-Raplp, 1:2,000 for mAb 414) in blotto. Ceils were washed several 
times with blotto and then incubated for 1 h at room temperature with a 
1:50 dilution of FITC or rhodamine-labeled anti-rabbit, mouse or rat sec- 
ondary antibodies from Cappel (Organon Teknika Corp., Durham, NC). 
After washing with blotto and then PBS, the DNA was stained with 1 Ixg/ 
ml DAPI in PBS and cells were mounted in 90% glycerol, 1 mg/ml phe- 
nylenediamine, pH 9.0. Coverslips were sealed with clear nail polish and 
slides stored at -20°C. 
Phosphate Labeling and Phosphatase Digestion 
Cells were grown overnight in low-phosphate YPD medium (Rubin, 
1975), diluted into fresh medium and grown to log phase. 1 mCi [32p]or- 
thophosphate (Amersham Corp.) was added to 5 ml cultures which were 
shaken at room temperature for one hour. Cells were pelleted, washed, 
and resuspended on ice in RIPA buffer (50 mM Hepes, pH 7.6, 150 mM 
NaC1, 1% Triton-X 100, 1% NaDeoxycholate, 0.1% SDS, 1 mM PMSF, 
LPC, 1 mM DTT, 50 mM NaF, 1 mM NaVanadate). An equal volume of 
glass beads was added and the cells were bead-beaten for 2 min at 4°C. 
Extracts were clarified, diluted to 1 ml with RIPA buffer and then 1 i~1 of 
anti-Madlp antibody and 10 ILl of protein A-Sepharose 6MB (Pharmacia) 
beads were added and incubated overnight at 4°C. Immunoprecipitates 
were washed several times with RIPA buffer, twice with PBS and once 
again with RIPA before heating the beads in sample buffer and separating 
the sample by SDS-PAGE. Gels were stained, fixed, dried down, and ex- 
posed to film overnight at -80°C. 
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For lambda protein phosphatase (LPP) treatments whole cell extracts 
were made by bead-beating yeast cells for 2 min in lysis buffer (50 mM 
Hepes, pH 7.6, 75 mM KCI, 1 mM MgCI~, 1 mM EGTA, 0.1% NP40, 1 
mM PMSF, LPC, 50 mM NaF, I mM NaVanadate) and DTI" was added to 
1 mM after clarification. Madlp was immunoprecipitated as described 
above and the immunoprecipitate was washed three times with lysis 
buffer, twice with PBS and then with LPP reaction buffer (50 mM Tris, pH 
8.0, 2 mM MnC12, 1 mM PMSF, LPC, 1 mg/ml acetylated BSA). 20 U of 
lambda protein phosphatase (New England Biolabs Inc., Beverly, MA) 
were added to the Madlp immunoprecipitate in 50 txl of LPP reaction 
buffer and incubated for 30 min at 30°C. Phosphatase inhibitors were 2 
mM ZnCI2, 1 mM NaVanadate and 50 mM NaF. The Sepharose beads 
were then spun down and heated in sample buffer before separating the 
sample by SDS-PAGE and analyzing Madlp by immunoblotting. 
Results 
MAD1 Is Predicted to Encode a Nove l  
Co i led-Coi l  Protein 
We cloned the wild-type MAD1 gene by complementing 
the benomyl sensitivity of the madl-1 mutant. The com- 
plementing plasmid rescued all three madl  alleles, did not 
rescue other benomyl sensitive mutants, and contained a 
DNA fragment that is closely linked to the MAD1 gene 
(see Materials and Methods). Sequencing the minimal 
complementing DNA fragment revealed a 2,250-bp read- 
ing frame which spans both an XhoI site and an XbaI site. 
Filling in either the XhoI site or the XbaI site destroyed 
the ability of this fragment to complement madl.  Two 
gene disruptions were made, one replacing the 3' half of 
the MAD1 gene with HIS3 and a second that replaced al- 
most the whole reading frame with the URA3 gene (see 
Fig. 1 and Materials and Methods). These constructs were 
used to transform haploid and diploid yeast strains. The 
disrupted haploid strains grow as well as wild-type cells at 
all temperatures tested, are sensitive to anti-microtubule 
drugs (see Fig. 3 a), and are unable to complement he 
madl  alleles previously isolated confirming that the dis- 
rupted reading frame is indeed MAD1. 
The DNA sequence and predicted translation of MAD1 
lkb 
SalI  XhoI  Xba[ Hind IH  H indUI  
YCP50 
I MAD1 ~ "... 
b. I " "  ORF 
C, madlA.1 
HIS3 
d . mad I d,2 
URA3 
Figure 1. Restriction map of the MAD1 clone and gene disrup- 
tions. (a) Restriction map of the MAD1 clone isolated from the 
YCP50 library showing the position of the open reading frame 
(ORF). Vector sequences are indicated by the thicker line. (b) 
Restriction map of the open reading frame (ORF). (c) The bar 
marks the HinclI fragments that were replaced with the HIS3 
gene to create madlA.1. (d) The bar marks the BgllI-XmnI frag- 
ment that was replaced with the URA3 gene to create madld.2. 
is shown in Fig. 2 a. The amino acid sequence of Madlp 
shows about 20% identity to a large number of proteins 
that contain or are predicted to contain regions of coiled- 
coil (e.g., myosin, integrins, NuMA [Yang et al., 1992], 
CENP-E [Yen et al., 1992], Usolp [Nakajima et al., 1991]). 
This homology is mainly due to the presence of heptad re- 
peats of hydrophobic residues, which are found through- 
out the MAD1 reading frame. Using the GCG computer 
program PEPCOIL we found that the bulk of Madlp does 
a -~14 TTATTTTAGTCTCTTATT~ATCGCTA~GGAGCAATGA~TTGATAGCGmGTTACCCTAGGAATAAT~CC7AACAATT7TTTCCATC$T 
-24 A~ATCGAGAGG~AATAGTA~T~TGGATGTGAGAGCGGCATTGCAATGTTTCTTCAGTGCAT~rGAG~GGACGAT~CACTGG~A 
MU R A A L Q C F F S A L S G R  7GKK 
~7 TTGGGACTAGAGATC~ATTCTATCCAGTAC~GAGC~TAGTGGTGGGTCCT~CCT~TCT~GGAAAG~CTGGAGG~TCGCCCGAC 
2 3 L G L E I ¥ S I Q y  M S N S G G S S P  L E S P G G S p D  
157 GTAGGCAGTACA~TGGACA~GT~TCGTCAGATTCAGGCGTTACAATTCAAGCTC~TACTCTACAAAATGAGTATGAGA~TGA~A 
5 3 V G S T N G Q S N R  I Q A L Q F K L N  LQNE E I Z ~  
247 TTG~AG~TACA~`r~CAGAC~AATATC~TAGAAAAGAAATAT~GGCCACGA~TGACGAATTAGAGAAAGCATTG~TGATACA~ATAT 
8 3 L Q L Q K Q T N I L  K K Y K A T I D E  E K A L  D T K Y  
337CTTTATG~GCAATGATAAATTGGAGC~GAGTT~GAGTTTG~AG~AGATCAGCTAATTCG~G~TGATA~GAC~ATGCATA 
I I 3 L Y E S N D K L E Q  L K S L K E R S A  S M N D  D K C I  
427GAGG~TTGCG~CAA~CCTCC~CAAAGATT~AGAAATG~AGACTTTAAGGCAGCAGTATGAT~CG~GTTATCAAAGGTCACT~C 
1 4 3 E E L R T T L Q N K  L E M E T L R Q Q  D S K L  K V T N  
5l7C~TGTGACCATTTCAAGTTGGAAGCAGAGAGCT~TCATTCGCTACTGATG~ATATGAGAAA~A~7~AGAGGCAAAGTGTGGATATC 
1 7 3 Q C O H F K L E A E S S H S L L M K Y E  Z : K R  $ V D I  
607 ~GATTTG~AGCATC~G~GATGG~AGGATGATG~TTATCTTCGGT~AAGcATC~AAGATGATAAACTCACATC~AAACTACTCC 
203KD Q N O V M E K D D E L $ S V K A S  M I N $  p N y S  
697 AC~G~GAGTT~AAC~AG~TC~CTGAAATGAA~aAA~GATC~AA~A~CAAn~TCAGTATACTAAAsAAT~GGAAC~AGCG~cATGCAA 
233~E ~ N E L T E M N K M I Q O Q V Q y  M E L E L A N M Q  
787 CAA~CC~TG~TTGAAAAAACTT~AACA~TCCCAGGACACTTCTACTTqTTGGAAATTAGAAAATGAAAAACTACAAkaCA~TTAAGT 
263QA E L K K L K Q S Q D T S T F W ~  ~ K L Q N K L S  
877 CAATTACACGTACTCGAAAGTCAATA~GAAAA~TTCA~TTGGAAAACATAGATCTAAAATCZAAATTA~CCAAATGGGAAATTTATAAT 
283QL V L E S Q Y E N  Q L E N I D L ~ S M L T K W E I y N  
96~ GATA~TGACGATGATGA~GAT~C~TGTTAAC~C~TGAT~T~AATAATAATAAAAATGATAATAATAATGATAATAAT~TGAT 
323DS D D O O N N V N N N ~ N N N N N ~ N n . N N n N N N D  
~57AC~GTAAT~C~CAA~ATqAA~TAACAACAGAACC~A~T~CATAAGAAA~AAC~T&AAGAGATTATCCGGGACTGGAAACTT 
353TS N N N ~ N N N  N T H H N I ~ N N P E ~ : I R D W R L  
1147 ACCAAAAAGG~TGTTTAATTTTGACAGATATG~TGATAAGTTA~GATTGGACAATAACAATTTAAAGCTACTGAATGATGAAATGGCT 
383TK E C L I L T D M  D K L  L D N N N L K L L N O E M A  
1237 TTAGAGAGAAACC~ATACTAGATTTGAAC~GAATTATGAAAACAAC~AGTAAATTTGAAAAGATTAAATCACGAGTTAG~CAACAG 
4 1 3 L E R N Q I L D L N K  yEN I V N L K ~ L N H E L E Q ~  
1327 ~GAGTTTATCTTTcc~GAATGT~GATTACTG~GCG~CAATTA~ATG~CC~A~AT~CCGCACAAA~TAATGCTTTACTAGAGGTCGAA 
4 4 3 K S L S F E E  R L L  E Q L  G L ¥ S A O N N A L L E V E  
1417 ~TAGTGA~CACATG~TCAAACAAGAACGTAAACG~GATATGAATAATTTGATCGATA~TATA~AAAThAGACAG~GATTTAACA 
4 7 3 N S E T N A 5  KNV E D M  N L I D T ~ N K T E ~ L T  
~5~7~C~AACT~`AA~CTA~GATCAGTTATTATC~ATTCCAATGATGTAGAAACACAAA~AAAAA~GAGGAAGTTGACAAGTGACCAA 
503NEL  ~ LN Q L L  N S N  V E T Q R K K R K L T S D Q  
1597 ATTG~TTT~TTATTCACAGAGGCTCAACGAATTGCAACTGGA~ATG~AAG~GTCTCGAGGnAGT~AGTAAAG~ACa~ACTAC~ATT 
5 3 3 1 G L M Y S Q  L N E L Q L Z  V S V S R E L S K A Q T T I  
168~ CAGCTACTACAAGAAAAATTAGAA~G~TAACN&A~CTA~GGAGAAAAAAATACGTATACT~CAAT~ACGTGACGGCCCCTTCATAAAA 
5 f i 3 Q L L Q E K L  E L T K L K E  K I R I L ~ L R O G P F I K  
~777GATC~TTTATC~G~CA~TT~C~TCTTCTAGAAAAGGAAAA~GCAGATTTACTTAACGAATTGAAAAAGAATAATCCAGCAGTG 
5 9 3 D Q F I K K N  L L I L E K E  A D L L N E L K K N N P A V  
1867 G~CAGTACCCATT~CTGTTTATGA~cACTAAATTTCGAGTTGAAA~AGTTCGAACAGGAAGT~zTxAAGTCAAATAAAAGATTTTCC 
6 2 3 E T V P l S V  D S L N F E L  Q F E Q E V F K S N K ~ F S  
1957AGACT~GC~GTTTT~AATAATAAATcTTTGGAGTTTATTGACGTTGTAAACTCATTA~TAGGTTTTAAA~TGG~TTTCAACAAGA7 
6 5 3 R L K Q V F N  K S L E F I D V V N S L L G F K L E F Q Q D  
2047 AGTCGTGTG~TATTTTCCTGTTTCAAACCTGAAAAATATTTGATTGCTGATCTAAATCAAAA~ACTTTGAAATCTAACCTTGATGCA 
6 8 3 $ N V K I ~ S C F K p E K Y L I A ~ L N E N ~ L K S N L D A  
213V GATATAG~GGAT~GGATGKTCTCATGAATCTATGGGTGGAAGATAGAGsTCAAC~TCCG7~CT~T~GGCAACAATAACATTGCGTCTG 
7 1 3 D I E G W D D L M N L W V E D ~ G Q L ? ~ F L A T I T L R L  
2227 TGGGAACAGCGACAAGCCAAATAAGTGTATATACATTTC~AATAGATAATAGTAATCGGTTTTATAA~A7GATAAA~T~CT~TCCGCTGA 
7 4 3 W E Q R Q A K "  
2317 CAT~TTGTT~GTCACAAAATT~TTTTATCTTTCTTCATCATTGA~CT~TTATGATTCCTTT~TATGCAAAAA~AAA~ATTGTGTTG 
2407 ~G~TAAAAACA~TTAC&GAA~AAGT~ACACATGATATAAA~GAAGCCCAGTTTTTCATAGCTATTAA~GGG~ATAAATGCACTTA 
2497 TATGA~G~GGTGATTCTAA~TCA~TCTG~GGATsTTGCTGTCCTCTCCATCA~CC~TAC~GGT~CG~CTTAACATTGATCTA 
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Figure 2. (a) Nucleotide sequence and translation of the MAD1 
gene. An unusual stretch of asparagine residues and the putative 
bi-partite nuclear localization signal are underlined. This se- 
quence is available from Genbank/EMBL/DDBJ under accession 
number U14632. (b) Coiled-coil prediction for Madlp. This 
GCG PEPCOIL prediction uses the algorithm of Lupas et al. 
(1991) with a window of 28 residues. 
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indeed have a high probability of forming coiled-coil (see 
Fig. 2 b) (Lupas et al., 1991). The sequence of Madlp also 
contains a putative bi-partite nuclear localization se- 
quence (residues 506-527) (Dingwall and Laskey, 1991), 
many potential phosphorylation sites and an unusual 
stretch rich in asparagine r sidues (residues 330-372). 
The MAD1 Gene Encodes a Component of the Spindle 
Assembly Checkpoint 
We studied madlA strains for defects in the spindle assem- 
bly checkpoint. The benomyl sensitivity of the original 
mad mutants could be rescued with hydroxyurea,  drug 
that lengthens S phase (Li and Murray, 1991). Since bud- 
ding yeast can assemble a spindle during S phase, our in- 
terpretation of this result is that the enforced delay in S 
phase allows mad cells enough time to correctly assemble 
b 
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Figure 3. Benomyl sensitivity of the madlA.1 strain (KH 123). 
(a) Yeast cells (KH 34, KH 123, KH 132, and KH 40) were spot- 
ted onto YPD plates containing the indicated concentrations of 
benomyl and hydroxyurea and were photographed after 3 d of 
growth at 23°C. (b) Microcolony analysis of the growth of yeast 
cells (KH 34, KH 123, and KH 40) on YPD plates containing 12 
ixg/ml benomyl at 23°C. Data was collected from at least 60 cells 
of each genotype. 
their mitotic spindle before initiating anaphase. Although 
1 mg/ml hydroxyurea slightly decreases the benomyl sensi- 
tivity of wild-type cells, it does not rescue the benomyl 
sensitivity of mutants with defects in microtubule poly- 
merization, such as cinlA (Fig. 3 a), even at lower concen- 
trations of benomyl (data not shown). Fig. 3 a shows that 
the madlA.1 deletion mutant behaves like the original 
madl and mad2-1 alleles: at 23°C it is sensitive to benomyl 
at concentrations of 7.5 ixg/ml and above, and this ben- 
omyl sensitivity can be rescued by i mg/ml hydroxyurea. 
We used microcolony assays to monitor the initial rate 
of cell division of madlA.1 strains on benomyl-containing 
medium. Individual, unbudded cells were picked with a 
dissecting needle and their growth on plates containing 12 
Ixg/ml benomyl was analyzed over a period of 8 hours. Fig. 
3 b shows that, like the original madl alleles, the madla.1 
strain initially divided faster than the wild-type control 
cells. This behavior of madla.1 differs radically from 
strains with defects in microtubule polymerization, which 
are unable to divide in the presence of benomyl and arrest 
as large budded cells. This result is consistent with 
madlA.1 cells being unable to sense or respond to the dis- 
ruption of their microtubules and thus initiating anaphase 
before spindle assembly is complete. It has previously 
been shown that mad mutants fail to maintain the mitotic 
activity of Cdc28p (monitored as histone H1 kinase activ- 
ity) when they are treated with benomyl (Li and Murray, 
1991). We have confirmed this result with madlA.1 (data 
not shown). 
Madlp Is a Soluble Nuclear Protein 
To analyze the properties of Madlp we raised polyctonal 
antibodies, against a GST fusion protein that contained 
Figure 4. Immunoblots of yeast extracts with anti-Madlp. (a) 
Whole cell extracts made from madlA.1 cells (KH 123), wild-type 
cells (KH 34) or wild-type cells containing the MAD1 gene on a 
centromeric (pKH130) or two-micron (pKH137) plasmid were 
immunoblotted with affinity-purified anti-Madlp antibodies. (b) 
Whole cell extracts made from wild-type (KH 34), the three orig- 
inal mad1 alleles (BEN 24, 27, and 76), or the two mad1 deletion 
strains constructed (KH 123, KH 131), were immunoblotted with 
affinity-purified anti-Madlp antibodies. The truncated protein 
expressed in madlzl.1 is indicated (*). 
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the amino-terminal half of Madlp. The serum was affinity 
purified and used to probe Western blots of whole cell ex- 
tracts from a number of yeast strains. Fig. 4 a shows that a 
protein of 90 kD that is seen in the wild-type cell extract is 
absent from the madlz l l  strain, and present at higher lev- 
els in strains containing MAD1 plasmids. A truncated 
Madl protein is expressed in madlA.1 where the 3' end of 
the MAD1 gene has been removed, and in two of the three 
previously isolated mad1 alleles (Fig. 4 b). The latter find- 
ing provides strong evidence that the reading frame we 
have identified is indeed the MAD1 gene and that the an- 
tiserum efficiently recognizes both wild-type and a num- 
ber of mutant Madl proteins. The affinity-purified anti- 
Madlp antiserum still recognizes a number of other pro- 
teins in addition to Madlp on immunoblots of whole yeast 
cell extracts, including a prominent band at 85 kD. How- 
ever, the cross-reacting proteins are not immunoprecipi- 
tated by the antibody (see Fig. 9), nor are they recognized 
well in formaldehyde-fixed yeast cells (Fig. 5), suggesting 
that they are unlikely to be closely related to Madlp. 
Immunofluorescence with affinity-purified anti-Madlp 
antibodies was used to localize Madlp within yeast cells. 
Fig. 5 reveals that the bulk of Madlp appears as discrete 
patches in the nucleus. The reactivity of Madlp is sensitive 
to fixation. We found that greater than 5 min of formalde- 
hyde fixation dramatically reduced Madlp staining and 
further fixation completely abolished it (data not shown). 
We used a number of antibodies to confirm that the struc- 
ture of the yeast nucleus was relatively intact after fixa- 
tion. Fig. 5 (e-j) shows that antibodies to tubulin (Adams 
and Pringle, 1984) and to the 90-kD component of the 
spindle-pole body (Rout and Kilmartin, 1990) gave the 
previously reported patterns, and that there was no consis- 
tent co-localization of these proteins with Madlp. In addi- 
tion, we found no co-localization of Madlp with Raplp (a 
telomere protein; Klein et al., 1992) or nuclear pore anti- 
gens (data not shown). Although we observed coincident 
localization of some of the Madlp staining and spindle 
pole bodies in a few cells, we conclude that Madlp has a 
novel nuclear localization pattern. 
Since some coiled-coil proteins form large insoluble oli- 
gomeric structures (Fuchs, 1994) we tested the solubility of 
Madlp. Yeast extracts were made by preparing sphero- 
plasts, douncing them and then extracting the homogenate 
with buffers containing various salts, detergents and nu- 
cleases. The extracts were then spun at 100,000 g to sepa- 
rate soluble from insoluble material. Pellet and superna- 
tant fractions were then run on SDS gels and blotted for 
Madlp (Fig. 6). Under all conditions the bulk of Madlp 
was found in the supernatant, but we reproducibly found 
that a minor fraction pelleted. However, even this fraction 
could be solubilized by a combined treatment with 1% Tri- 
ton/1 M NaC1/DNase and RNase, suggesting that Madlp is 
unlikely to be a constituent of the nuclear scaffold (Mirza- 
yan et al., 1992). 
Another striking characteristic of coiled-coil proteins is 
Figure 6. Madlp solubility, sizing and sedimentation a alyses. 
(a) The bulk of Madlp behaves as a 'soluble protein. Yeast cells 
(KH 34) were spheroplasted an homogenized. Aliquots of this 
homogenate were then extracted with either 1% Triton X-100, 
1 M NaC1 or a combination of 1% Triton, 1 M NaC1, 0.25 mg/ml 
DNase and RNase, before being spun at 100,000 g for 30 min. 
Pellet and supernatant fractions were immunoblotted with affin- 
ity-purified anti-Madlp antibodies. Yeast extracts were made 
from wild-type (KH 34) cells by bead-beating, spun at 100,000 g
for 30 min, and then (b) loaded over a Superose 6 gel filtration 
column, or (c) fractionated by centrifugation through a 5-40% 
sucrose gradient. Fractions wereimmunoblotted with affinity-puri- 
fied anti-Madlp antibodies. Madlp is the uppermost band in b 
and c and the molecular masses of marker proteins are indicated. 
their rod shape. To assess the hydrodynamic behavior of 
Madlp we fractionated yeast extracts by gel filtration and 
sucrose gradient sedimentation. Fig. 6 b shows that Madlp 
behaves as a very large protein on gel filtration, running 
ahead of the 670-kD thyroglobulin marker. A similar size 
for Madlp was obtained by immunoblotting yeast extracts 
that had been separated in their native state by gradient 
gel electrophoresis (not shown). However, Madlp sedi- 
ments relatively slowly through sucrose gradients, peaking 
in the same fraction as the 4.4 S BSA marker (Fig. 6 c). 
Neither the sedimentation nor the gel filtration behavior 
of Madlp was altered by the presence of 1 M NaC1 (not 
shown). Similar fractionation behavior has been reported 
Figure 5. Immunofluorescent staining of yeast cells with anti-Madlp. Wild-type (a and b) (KH 34) and madlA.1 (c and d) (KH 123] cells 
were stained with affinity-purified anti-Madlp antibodies (b and d) and DAPI (a and c). Patchy nuclear staining is observed in wild- 
type cells and is absent in the madlA.1 cells. Wild-type diploid cells (KH 36) were stained with DAPI (e and h), anti-Madlp (f and i), 
and either anti-tubulin (g) orpooled mAbs to the 90-kD component ofthe SPB (j). Bars, 10 Ixm. 
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Figure 7. The ability to modify Madlp is restricted to certain por- 
tions of the cell cycle. Wild-type (KH 34) cells were arrested with 
a-factor and then released into YPD or YPD containing 15 Ixg/ml 
benomyl. Cells were taken at the times indicated and extracts 
were immunoblotted using anti-Madlp and anti-Clb2p anti- 
bodies. 
for other coiled-coil proteins, such as myosin and kinesin 
(Hackney et al., 1992; Hirano and Mitchison, 1994). We 
therefore propose that Madlp has a large Stokes' radius 
and that it may be rod shaped, consistent with the elon- 
gated structure of many coiled-coil proteins. 
Modification of Madlp by Phosphorylation 
Does cell cycle progression or activation of the spindle as- 
sembly checkpoint alter the abundance or posttransla- 
tional modification of Madlp? To answer these questions 
we examined cells released from a G1 arrest into normal 
or benomyl containing medium. Wild-type cells were ar- 
rested in G1 with a-factor and then released into YPD or 
YPD containing 15 p~g/ml benomyl. Samples were col- 
lected over two cell cycles and analyzed for the abundance 
of Madlp by immunoblotting. To monitor the timing of 
the cell cycle, these blots were also probed with antibodies 
to the mitotic yclin Clb2p which is degraded at the end of 
mitosis. Fig. 7 shows that the abundance of Madlp re- 
mains constant through the cell cycle and is not affected by 
benomyl-induced mitotic arrest. During a normal cell cy- 
cle there is only a minor variation in the gel mobility of 
Madlp, however a significant fraction of the protein de- 
creases in gel mobility when cells are arrested in mitosis by 
benomyl treatment (similar results were obtained with no- 
codazole; data not shown). The low level of Madlp modi- 
fication seen in untreated cells may be induced by tran- 
sient spindle defects that occur in the course of normal 
spindle assembly. Figs. 9 and 10 clearly demonstrate that 
the slower migrating bands are forms of Madlp and not 
cross-reacting proteins that accumulate in mitosis. 
The slower migrating form of Madlp appears in mitoti- 
cally arrested cells whose levels of Clb2p are high, suggest- 
ing that modification of Madlp is a specific response to 
a disrupted spindle. To test this hypothesis we asked 
whether Madlp was modified when cells arrested at Start 
with a-factor were treated with benomyl (Fig. 8 a). Half of 
the a-factor-arrested cells were treated with 30 ixg/ml 
benomyl in the continuous presence of a-factor to prevent 
their passage through Start. The other half were released 
from their a-factor arrest into YPD containing benomyl. 
Fig. 8 a shows that benomyl treatment of cells maintained 
at the a-factor arrest point causes much less modification 
of Madlp than releasing cells from a-factor arrest into 
benomyl. The low level of Madlp modification seen after 
2 h of combined treatment with a-factor and benomyl 
probably represents a fraction of the cells that have bro- 
ken through the a-factor arrest. This experiment shows 
that the modification of Madlp is not simply a response to 
benomyl, but is seen only in cells in the portion of the cell 
cycle where spindle assembly can occur. 
To determine whether other mitotic arrests are accom- 
panied by Madlp modification, we analyzed Madlp in 
number of other mutants. Fig. 8 b shows that the modifica- 
tion of Madlp is not seen in either cdc23 mutants which 
prevent the ubiquitin-mediated proteolysis necessary to 
initiate anaphase and thus arrest early in mitosis with short 
spindles (Irniger et al., 1995), or in cdc15 mutants which 
arrest later in mitosis with long spindles (Surana et al., 
1993). This result demonstrates that Madlp modification 
Figure 8. Madlp is not modified when 
alpha-factor arrested cells are treated 
with benomyl, or in cdc23 and cdcl5 
mitotic arrests, but it is in a tub2 mi- 
totic arrest. (a) Wild-type cells (KH 34) 
were arrested with a-factor and then 
treated with 30 ~zg/ml benomyl, either 
with or without releasing them from 
the c~-factor arrest. The modification of 
Madlp was analyzed by immunoblot- 
ting. (b) Wild-type (KH 34), cdc15-2 
(KH 161), and cdc23 (KH 162) mutants 
were arrested in G1 with a-factor, re- 
leased, and then grown at 37°C for 2 h. 
The modification of Madlp was ana- 
lyzed by immunoblotting. (c) Wild- 
type (KH 146) and tub2-403 (KH 152) 
cells were arrested in G1 with a-factor, 
released, and then grown at 15°C. Lev- 
els and modification of Clb2p and 
Madlp were analyzed byimmunoblot- 
ting. 
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requires pindle perturbations in addition to an arrest with 
high levels of Cdc28-Clb-associated kinase activity. 
To test whether other methods of disrupting spindle mi- 
crotubules lead to the modification of Madlp, we com- 
pared synchronous cultures of wild-type and cold-sensitive 
tub2-403 strains (Huffaker et al., 1988) that had been ar- 
rested with a-factor and then released at 15°C. Fig. 8 c 
shows that the tub2 mutant arrests in mitosis with high lev- 
els of Clb2p and that a significant fraction of Madlp is 
modified. In addition, we note that Madlp is transiently 
modified in the wild-type cells, and that this occurs before 
the levels of Clb2p peak, when the spindle is presumably 
being assembled. Such modification can be seen in wild- 
type cells growing at higher temperatures ( ee Fig. 7) but 
is less obvious, consistent with it being a response to tem- 
perature-induced spindle perturbations (Dustin, 1984). 
Is the reduced gel mobility of Madlp due to phosphoryla- 
tion? To test this possibility we immunoprecipitated Madlp 
from logarithmically growing and benomyl-arrested cells 
and treated the immunoprecipitates with lambda protein 
phosphatase. Fig. 9 a shows that phosphatase treatment 
eliminates the slower migrating forms of Madlp, consis- 
tent with the reduced mobility resulting from phosphory- 
lation. Treatment with lambda protein phosphatase in the 
presence of phosphatase inhibitors has no effect on the gel 
mobility of Madlp. As not all protein phosphorylations 
are accompanied by a gel shift we also analyzed Madlp in 
cells that were metabolically labeled with [32p]orthophos- 
phate. Extracts were prepared from exponentially growing 
or cell cycle-arrested cultures, immunoprecipitated with 
the polyclonal anti-Madlp antiserum, and analyzed by gel 
electrophoresis and autoradiography. Fig. 9 b shows that 
phosphate incorporation into Madlp occurs to equal ex- 
tents in exponentially growing, benomyl-arrested, and a-fac- 
tor-arrested ceils, suggesting that Madlp is phosphory- 
lated throughout the cell cycle. Our inability to see more 
slowly migrating phosphate labeled forms of Madlp in 
benomyl-treated cells may reflect the relatively low level 
of labeling, or the poor mitotic arrest produced by benomyl 
treatment in low phosphate medium, or both. 
We also examined the phosphorylation of the N-termi- 
nal half of Madlp that is expressed in the madlA.1 strain. 
Although 32p is incorporated into this fragment as effi- 
ciently as it is into the wild-type protein (Fig. 9), none of 
the original mad1 alleles nor this truncated protein (not 
shown) show the mobility shift that occurs when wild type 
cells are treated with benomyl (Fig. 10 a). These findings 
indicate that Madlp is the target for two types of phospho- 
rylation: constitutive phosphorylation that appears to oc- 
cur throughout the cell cycle and on both functional and 
Figure 9. Madlp is phosphorylated. (a)Madlp was immunopre- 
cipitated from wild-type extracts made from cells (KH 34) grow- 
ing in YPD (log) or YPD with 30 ~g/ml benomyl. The indicated 
immunoprecipitates were treated with lambda protein phos- 
phatase, in the presence or absence of phosphatase inhibitors 
(inh), and then immunoblotted with anti-Madlp. (b) Madlp 
was immunoprecipitated from [32p]orthophosphate-labeled cells. 
Wild-type cells (KH 34) were grown in low phosphate YPD me- 
dium or the same medium containing either 10 p.g/ml a-factor or 
30 ~g/ml benomyl. The rnadlA.1 (KH 123), madlA.2 (KH 13I), 
and bublA (KH 127) cells were all grown in low phosphate YPD 
medium. 
Figure 10. Hyperphosphorylation of Madlp in spindle assembly 
checkpoint mutants. (a) Wild-type (KH 34) and the three original 
madl alleles (BEN 24, 27, and 76) were grown to log phase and 
treated with 30 ixg/ml benomyl for 3 h. Whole cell extracts were 
immunoblotted with anti-Madlp. (b) Wild-type (KH 34), madlA.1 
(KH 123), mad2-1 (KH 132), mad3A (KH 125), bublA (KH 127), 
bub2A (KH 128), and bub3A (MAY 2072) strains were grown to 
log phase, and then treated with 30 ~g/ml benomyl for 3 h. Whole 
cell extracts were made and immunoblotted with anti-Madlp. 
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non-functional forms of Madlp, and a regulated phospho- 
rylation that is induced by activation of the spindle assem- 
bly checkpoint and occurs only on functional Madlp. 
We asked whether Madlp was hyperphosphorylated in 
mutants defective in the spindle assembly checkpoint. To 
do this we examined the gel mobility of Madlp in extracts 
made from wild type, mad, or bub strains that were grown 
in the absence or presence of 30 ixg/ml benomyl. Fig. 10 b 
shows that Madlp hyper-phosphorylation was undimin- 
ished in the mad3A and bub2A mutants, from which we 
conclude that neither Mad3p nor Bub2p are necessary for 
this modification of Madlp. However, the hyperphospho- 
rylation of Madlp was dramatically reduced in mad2-1, 
and absent in the bublA and bub3A mutant strains. This 
shows that Bublp, Bub3p, and Mad2p are all important 
for this modification of Madlp. The observation that 
Bublp is a novel protein kinase (Roberts et al., 1994) 
prompted us to ask whether this protein is required for all 
phosphorylation events on Madlp. Madlp is still phos- 
phate labeled in the bublA strain showing that Bublp is 
not required for the addition of all phosphate groups to 
Madlp (Fig. 9 b). 
Discussion 
We have cloned the MAD1 gene and shown that it en- 
codes a novel nuclear phosphoprotein that is predicted to 
form coiled-coils. Like the previously isolated madl al- 
leles, madlA cells are unable to delay initiation of ana- 
phase in response to microtubule depolymerization a d 
thus suffer a high frequency of chromosome loss and rapid 
death upon treatment with anti-microtubule drugs. Spin- 
dle disruption is accompanied by a Madlp phosphoryla- 
tion that reduces the mobility of the protein and this mod- 
ification requires the Bublp, Bub3p and Mad2p functions, 
but not Bub2p and Mad3p, suggesting that this phosphory- 
lation plays an important role in the spindle assembly 
checkpoint. 
Antibodies to Madlp reveal that the protein has a non- 
uniform distribution within the nucleus. All cells show a 
diffuse punctate staining and many also have a small num- 
ber of brightly staining loci. Neither staining pattern re- 
producibly colocalizes with nuclear pores, spindle-pole 
bodies or telomeres, suggesting that the Madlp may be 
found at a novel location within the nucleus. Identifying 
the Madlp-containing structures will require immunoelec- 
tron microscopy or isolating Madlp homologs from organ- 
isms with better cytology. In cell extracts Madlp is largely 
soluble, and its hydrodynamic behavior suggests hat Madlp 
has an elongated shape like many other coiled-coil proteins. 
Analyzing the gel mobility and phosphate labeling of 
Madlp has revealed both a constitutive l vel of phospho- 
rylation, seen in all stages of the cell cycle that we ana- 
lyzed, and a hyper-phosphorylation induced by spindle de- 
polymerization. The former phosphorylation is seen in 
exponentially growing cells as well as in G1 and mitotically 
arrested cells, suggesting that it occurs throughout the cell 
cycle. We do not know the identity of the constitutive phos- 
phorylation site(s), or whether their modification plays 
any role in the spindle assembly checkpoint. The regulated 
phosphorylation reduces the gel mobility of Madlp and is 
seen only in those parts of the cell cycle in which cells are 
able to assemble a spindle. The modification is detectable 
at a low level in normally growing cells, and is much more 
pronounced in benomyl treated cells suggesting that it 
may be induced by activation of the spindle assembly 
checkpoint. The low level of Madlp hyperphosphorylation 
in wild type cells could either eflect full activation of the 
spindle assembly checkpoint in a small fraction of the pop- 
ulation with transient spindle defects, or weak activation 
in all cells during the course of spindle assembly. We find 
that wild-type cells growing in the cold show higher levels 
of Madlp modification, and that the tub2-403 mutant ar- 
rests in the cold in mitosis with hyperphosphorylated 
Madlp, showing that Madlp modification is not solely a 
response to drug-induced spindle perturbations. In addi- 
tion we find that Madlp receives little modification in 
cdc23 and cdc15 mutant arrests, ruling out the possibility 
that the hyperphosphorylation of Madlp is simply a by- 
product of any cell cycle arrest with active Cdc28-Clb2 
complexes. But if cdc23 mutants are first arrested at 37°C 
and then treated with benomyl without releasing them 
from the arrest Madlp does become hyperphosphorylated 
(data not shown), showing that spindle disassembly at this 
metaphase-like arrest can be readily detected by the 
checkpoint. 
Examining Madlp hyper-phosphorylation n mad and 
bub mutants trengthens the case that this modification 
plays an important role in the spindle assembly check- 
point. There is no mobility shift in mad1-1, mad1-2, mad1- 
3, or madlA.1. This observation suggests that the proper 
function of Madlp is needed for its own modification and 
is especially significant for mad1-2, which encodes an ap- 
parently full length protein. The modification of wild-type 
Madlp does not occur in the bubl and bub3 mutants and 
is strongly reduced in the mad2 mutant. Although the cor- 
relative evidence is strong, proof that Madlp hyperphos- 
phorylation is necessary for the spindle assembly check- 
point will require the identification and mutation of the 
regulated Madlp phosphorylation sites. 
We assume that the spindle assembly checkpoint must 
consist of at least three classes of component: a detection 
system that monitors the structure of the spindle, a signal 
transduction pathway that relays this information, and a 
target in the cell cycle machinery whose regulation can 
produce amitotic arrest. Even if the mobility shift of Madlp 
is no more than a correlation with the activation of the 
spindle assembly checkpoint, it represents he first tool for 
ordering the functions in this pathway. The simplest inter- 
pretation of our data is that Madlp lies ia the middle of 
the checkpoint pathway and that mutants that fail to hy- 
perphosphorylate this protein identify proteins that act 
upstream of Madlp, whereas mutants that can modify 
Madlp identify proteins that act downstream of Madlp 
(Fig. 11). Clearly our results do not allow us to rule out 
other more complicated models. For example, Bub2p and 
Mad3p need not be directly downstream of Madlp but 
could instead be in a parallel pathway whose action is re- 
quired for cell cycle arrest but not for the hyperphos- 
phorylation of Madlp. The isolation of dominant alleles of 
MAD1, and of the other MAD and BUB genes, that cause 
a mitotic arrest should enable us to order the function of 
these genes within the spindle assembly checkpoint more 
precisely. 
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Figure 11. A model suggesting the order of function in the spin- 
dle assembly checkpoint. See text for details. 
Previous work identifies three candidates for the physio- 
logical Madlp kinase. The demonstration that Bublp is a 
protein kinase that can phosphorylate itself and Bub3p in 
vitro (Roberts et al., 1994), and the inability of bubl cells 
to hyperphosphorylate Madlp make Bublp a good candi- 
date for a Madlp-kinase. The MPS1 gene product is an- 
other candidate, since it has protein kinase activity in vitro 
and is required for the spindle assembly checkpoint to de- 
tect defects in spindle pole body duplication (Weiss, E., 
and M. Winey, personal communication). Finally, the ob- 
servation that activation of the spindle assembly check- 
point in frog egg extracts requires the activities of MAP ki- 
nases suggests that members of this kinase family are also 
candidates for the Madlp kinase (Minshull et al., 1994). 
By identifying the sites of benomyl-dependent Madlp 
phosphorylation we hope to determine their role in the 
spindle assembly checkpoint and to identify the kinases 
and phosphatases that regulate this modification. 
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